216 related articles for article (PubMed ID: 27184646)
21. Dosimetric assessment of an air-filled balloon applicator in HDR vaginal cuff brachytherapy using the Monte Carlo method.
Jiang H; Badkul R; Pokhrel D
J Appl Clin Med Phys; 2018 May; 19(3):101-107. PubMed ID: 29493101
[TBL] [Abstract][Full Text] [Related]
22. The optimization of dose delivery for intraoperative high-dose-rate radiation therapy using curved HAM applicators.
Beddar AS; Krishnan S; Briere TM; Wang X; Delclos ME; Ballo MT; Das P; Gould S; Horton JL; Crane CH
Radiother Oncol; 2006 Feb; 78(2):207-12. PubMed ID: 16376445
[TBL] [Abstract][Full Text] [Related]
23. Asymmetric dose-volume optimization with smoothness control for rotating-shield brachytherapy.
Liu Y; Flynn RT; Kim Y; Wu X
Med Phys; 2014 Nov; 41(11):111709. PubMed ID: 25370623
[TBL] [Abstract][Full Text] [Related]
24. A dosimetric comparison of CT- and photogrammetry- generated 3D printed HDR brachytherapy surface applicators.
Bridger CA; Reich PD; Caraça Santos AM; Douglass MJJ
Phys Eng Sci Med; 2022 Mar; 45(1):125-134. PubMed ID: 35020174
[TBL] [Abstract][Full Text] [Related]
25. Intraoperative high-dose-rate brachytherapy: An American Brachytherapy Society consensus report.
Lloyd S; Alektiar KM; Nag S; Huang YJ; Deufel CL; Mourtada F; Gaffney DK
Brachytherapy; 2017; 16(3):446-465. PubMed ID: 28173994
[TBL] [Abstract][Full Text] [Related]
26. Single magnetic resonance imaging vs magnetic resonance imaging/computed tomography planning in cervical cancer brachytherapy.
Beriwal S; Kim H; Coon D; Mogus R; Heron DE; Li X; Huq MS
Clin Oncol (R Coll Radiol); 2009 Aug; 21(6):483-7. PubMed ID: 19423307
[TBL] [Abstract][Full Text] [Related]
27. Monte Carlo skin dose simulation in intraoperative radiotherapy of breast cancer using spherical applicators.
Moradi F; Ung NM; Khandaker MU; Mahdiraji GA; Saad M; Abdul Malik R; Bustam AZ; Zaili Z; Bradley DA
Phys Med Biol; 2017 Jul; 62(16):6550-6566. PubMed ID: 28708603
[TBL] [Abstract][Full Text] [Related]
28. Intraoperative optimization of needle placement and dwell times for conformal prostate brachytherapy.
Edmundson GK; Yan D; Martinez AA
Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1257-63. PubMed ID: 7493850
[TBL] [Abstract][Full Text] [Related]
29. Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy.
Cunha JA; Pouliot J; Weinberg V; Wang-Chesebro A; Roach M; Hsu IC
Brachytherapy; 2012; 11(5):348-53. PubMed ID: 21937284
[TBL] [Abstract][Full Text] [Related]
30. HDR brachytherapy of rectal cancer using a novel grooved-shielding applicator design.
Webster MJ; Devic S; Vuong T; Han DY; Scanderbeg D; Choi D; Song B; Song WY
Med Phys; 2013 Sep; 40(9):091704. PubMed ID: 24007137
[TBL] [Abstract][Full Text] [Related]
31. Fast automated multi-criteria planning for HDR brachytherapy explored for prostate cancer.
Breedveld S; Bennan ABA; Aluwini S; Schaart DR; Kolkman-Deurloo IK; Heijmen BJM
Phys Med Biol; 2019 Oct; 64(20):205002. PubMed ID: 31530761
[TBL] [Abstract][Full Text] [Related]
32. Towards artificial intelligence-based automated treatment planning in clinical practice: A prospective study of the first clinical experiences in high-dose-rate prostate brachytherapy.
Barten DLJ; Pieters BR; Bouter A; van der Meer MC; Maree SC; Hinnen KA; Westerveld H; Bosman PAN; Alderliesten T; van Wieringen N; Bel A
Brachytherapy; 2023; 22(2):279-289. PubMed ID: 36635201
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of using multiple-dwell positions in
Tien CJ; Pinkham DW; Chen ZJ
Brachytherapy; 2020; 19(4):532-543. PubMed ID: 32327342
[TBL] [Abstract][Full Text] [Related]
34. HDR brachytherapy with surface applicators: technical considerations and dosimetry.
Sabbas AM; Kulidzhanov FG; Presser J; Hayes MK; Nori D
Technol Cancer Res Treat; 2004 Jun; 3(3):259-67. PubMed ID: 15161319
[TBL] [Abstract][Full Text] [Related]
35. Comparison of
Safigholi H; Meigooni AS; Song WY
Med Phys; 2017 Sep; 44(9):4426-4436. PubMed ID: 28494095
[TBL] [Abstract][Full Text] [Related]
36. Automated treatment planning framework for brachytherapy of cervical cancer using 3D dose predictions.
Kallis K; Moore LC; Cortes KG; Brown D; Mayadev J; Moore KL; Meyers SM
Phys Med Biol; 2023 Apr; 68(8):. PubMed ID: 36898161
[No Abstract] [Full Text] [Related]
37. High-dose-rate brachytherapy of rhabdomyosarcoma limited to the external auditory canal.
King MT; Voros L; Cohen GN; Lanning RM; Ganly I; O'Suoji CC; Wolden SL
Brachytherapy; 2017; 16(1):181-185. PubMed ID: 27528589
[TBL] [Abstract][Full Text] [Related]
38. Dosimetric analysis of a shielded applicator for nasopharyngeal carcinoma intracavitary brachytherapy: Monte Carlo calculation.
Chen LX; Liu XW; You RA; Qian JY; Qi ZY; Deng XW; Tsao SY
Med Phys; 2006 Mar; 33(3):761-9. PubMed ID: 16878578
[TBL] [Abstract][Full Text] [Related]
39. Commissioning of a 3D image-based treatment planning system for high-dose-rate brachytherapy of cervical cancer.
Kim Y; Modrick JM; Pennington EC; Kim Y
J Appl Clin Med Phys; 2016 Mar; 17(2):405-426. PubMed ID: 27074463
[TBL] [Abstract][Full Text] [Related]
40. The influence of the dwell time deviation constraint (DTDC) parameter on dosimetry with IPSA optimisation for HDR prostate brachytherapy.
Smith RL; Panettieri V; Lancaster C; Mason N; Franich RD; Millar JL
Australas Phys Eng Sci Med; 2015 Mar; 38(1):55-61. PubMed ID: 25481387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
